Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile

Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME27458D
  • |
  • Pages: 68
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Astellas Pharma Inc (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company's product portfolio comprises both marketed and pipeline products for the treatment of a wide range of diseases in the areas of urology, transplantation, immune deficiency, infectious diseases, cancer, neuroscience, and metabolic diseases, among others. The company sells its products under the brand names such as Prograf, Vesicare, Geninax, and Eligard among others. It has operations in several countries across the Americas; Europe, Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Astellas Pharma Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Euroscreen Raises USD17.8 Million in Series B Financing Round 12

Partnerships 13

Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 13

Qiagen Enters into Co-Development Agreement with Astellas Pharma 14

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 15

Equity Offering 16

Advanced Cell to Raise USD30 Million in Private Placement of Shares 16

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 17

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 17

Acquisition 18

Astellas Pharma Acquires Ganymed Pharma 18

Daiichi Sankyo Completes Acquisition Of Plexxikon 20

Astellas Pharma Inc-Key Competitors 23

Key Employees 24

Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 35

Strategy And Business Planning 35

Dec 08, 2016: Astellas Research & Development Meeting Highlights 35

Financial Announcements 37

Apr 27, 2017: Astellas Reports Full Year FY2016 Financial Results 37

Jan 31, 2017: Astellas Reports the First Nine Months Financial Results of FY2016 39

Oct 27, 2016: Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year Outlook 41

Jul 29, 2016: Astellas Reports First Quarter Financial Results of FY2016 43

Jan 26, 2016: Financial Results Of Astellas For First Nine Months of FY2015 45

Corporate Communications 46

Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations 46

May 11, 2017: Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas 47

Apr 28, 2017: Astellas Announces Key Leadership Promotions in Development Organization 48

Apr 27, 2017: Astellas Pharma Announces Changes of Representative Directors and Directors 49

Feb 08, 2017: Astellas Announces Changes in Management Structure and Global Function 51

Feb 08, 2017: Astellas Announces Personnel Changes and Organizational Changes 53

Aug 23, 2016: Astellas Announces Personnel Changes 55

Jul 18, 2016: Astellas Promotes John Demaree to Vice President of Oncology Marketing in the Americas Region 56

May 31, 2016: Astellas Announces Personnel Changes 57

Apr 27, 2016: Astellas Announces Changes to Representative Director and Audit & Supervisory Board Member 58

Apr 25, 2016: Astellas Announces Key Leadership Appointments in Ethics and Compliance and US Legal Organizations 59

Mar 04, 2016: Astellas Announces Leadership Changes 60

Feb 08, 2016: Astellas Names James Robinson President, Americas Operations 61

Feb 08, 2016: Astellas Announces Personnel Changes and Organizational Changes 62

Legal and Regulatory 63

May 31, 2017: Astellas Announces New Global Website Launch 63

Jul 06, 2016: Astellas Named to FTSE4Good Sustainability Index for the Fifth Consecutive Year 64

Government and Public Interest 65

Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year 65

Other Significant Developments 66

Aug 08, 2016: Proteostasis Therapeutics Achieves Preclinical Milestone in Astellas Pharma Collaboration 66

Apr 01, 2016: Establishment and Start of Operations of Malaysia Subsidiary and Umbrella Organization Covering South East and South Asia Regions 67

Appendix 68

Methodology 68

About GlobalData 68

Contact Us 68

Disclaimer 68

List of Figures

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Astellas Pharma Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Astellas Pharma Inc, Medical Equipment, Key Facts, 2016 1

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Astellas Pharma Inc, Deals By Market, 2011 to YTD 2017 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Euroscreen Raises USD17.8 Million in Series B Financing Round 12

Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma 13

Qiagen Enters into Co-Development Agreement with Astellas Pharma 14

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 15

Advanced Cell to Raise USD30 Million in Private Placement of Shares 16

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million 17

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million 17

Astellas Pharma Acquires Ganymed Pharma 18

Daiichi Sankyo Completes Acquisition Of Plexxikon 20

Astellas Pharma Inc, Key Competitors 23

Astellas Pharma Inc, Key Employees 24

Astellas Pharma Inc, Key Employees 26

Astellas Pharma Inc, Other Locations 28

Astellas Pharma Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Astellas Pharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16020
Site License
USD 500 INR 32040
Corporate User License
USD 750 INR 48060

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com